Related references
Note: Only part of the references are listed.SIRT1 Regulates CD40 Expression Induced by TNF-α via NF-κB Pathway in Endothelial Cells
Lina Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-κB activity
Lei Ming et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Effect of resveratrol on platelet activation in hypercholesterolemic rats: CD40-CD40L system as a potential target
Ayse Yesim Gocmen et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM-PHYSIOLOGIE APPLIQUEE NUTRITION ET METABOLISME (2011)
Delphinidin, a specific inhibitor of histone acetyltransferase, suppresses inflammatory signaling via prevention of NF-κB acetylation in fibroblast-like synoviocyte MH7A cells
Ah-Reum Seong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1
Emma Barroso et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation
Ana Planavila et al.
CARDIOVASCULAR RESEARCH (2011)
Protective roles of SIRT1 in atherosclerosis
Sokrates Stein et al.
CELL CYCLE (2011)
Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation
Atsuko Tomizawa et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice
Sokrates Stein et al.
AGING-US (2010)
Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: Role of circulating factors and SIRT1
Anna Csiszar et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2009)
Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations
Anna Csiszar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
SIRT1 longevity factor suppresses NF-κB -driven immune responses: regulation of aging via NF-κB acetylation?
Antero Salminen et al.
BIOESSAYS (2008)
CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease
Muhammad Rizvi et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Tanshinone IIA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet
Zhi-yuan Fang et al.
LIFE SCIENCES (2007)
PPARα in atherosclerosis and inflammation
Fokko Zandbergen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction
Marcia C. Haigis et al.
GENES & DEVELOPMENT (2006)
Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance
B Okopien et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-κB activity
TL Yang et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
Lovastatin reduces nuclear factor kappa B activation induced by C-reactive protein in human vascular endothelial cells
R Lin et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase
F Yeung et al.
EMBO JOURNAL (2004)
C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenotibrate on it in human vascular endothelial cells
R Lin et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Cytoplasmic IκBα increases NF-κB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3
P Viatour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
HL Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65
R Kiernan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Reduction of atherosclerosis by the peroxisome proliferator-activated receptor α agonist fenofibrate in mice
H Duez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Acetylation of ReIA at discrete sites regulates distinct nuclear functions of NF-κB
LF Chen et al.
EMBO JOURNAL (2002)
Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1
KJ Bitterman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα
HE Xu et al.
NATURE (2002)
Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening
CM Grozinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Peroxisome proliferator-activated receptors in inflammation control
P Delerive et al.
JOURNAL OF ENDOCRINOLOGY (2001)
NF-kappa B: a key role in inflammatory diseases
PP Tak et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
